Vanguard Group Inc Hoth Therapeutics, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.36 - $9.25 $63,957 - $1.64 Million	177,659 Added 23.23%	942,305 $328,000
Q1 2022 May 13, 2022	BUY	$0.52 - $1.3 $28,392 - $70,980	54,600 Added 7.69%	764,646 $529,000
Q3 2021 Nov 12, 2021	BUY	$1.15 - $1.62 $4,428 - $6,238	3,851 Added 0.55%	710,046 $845,000
Q2 2021 Aug 13, 2021	BUY	$1.31 - $2.14 $925,115 - $1.51 Million	706,195 New	706,195 $1.13 Million

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.04M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.